{
}
Sanofi is selling a 50% stake in its Opella subsidiary, which includes Doliprane, to the American private equity firm CD&R, known for investing in unlisted companies since 1978. With an enterprise value of approximately 16 billion euros, CD&R aims to enhance Opella's growth and establish it as a leader in consumer healthcare. Sanofi will retain about 48% ownership, while Bpifrance is expected to acquire a small stake.
Marty Dubilier
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
cd and r to acquire 50 percent stake in sanofi's opella subsidiary
United States Dollar
Rexel S.A.
Sanofi
Veolia Voda
FRA
Joe Rice
Eric Rouzier
Gene Clayton
Marty Dubilier
Show more
13:30 21.10.2024
Trending
Subcategory
Industry Trends
Corporate News
Startups & Entrepreneurship
Supply Chain Management
Global Trade Developments
Industry Mergers & Acquisitions
Government Economic Policies
Cryptocurrency Trends
Financial Scams and Security
Workplace Trends
CEO Changes
Venture Capital Investments
Finance Mergers & Acquisitions
Funding Rounds & Investments
Fintech Startups
Emerging Startups
Consumer Protection Regulations
Retail and Consumer Goods
Market Analysis and Predictions
Global Trade Policies
Countries:
Companies:
Apple Inc.
Google Inc.
NVIDIA Corporation
Delhivery Limited
Ecom Express Ltd.
Alphabet Inc.
OpenAI ERC USD
Ciscom Corp.
ERICSSON - CLASS B
Physicswallah Ltd.
Snap Inc.
Tiktok USD
Semiconductor Manufacturing International Corporation
Hua Hong Semiconductor Ltd.
Spotify Technology S.A.
Dropbox, Inc.
Vimeo, Inc.
Adobe Inc.
Airbnb, Inc.
SpaceXCoin USD
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Vietnamese Đồng
Russian Ruble
South Korean Won
Pakistani Rupee
Algerian Dinar
Australian Dollar
Thai Baht
New Taiwan Dollar
People: